193 related articles for article (PubMed ID: 22359202)
1. Quantitative assessment of the associations between CYP1A1 polymorphisms and gastric cancer risk.
Guo R; Guo X
Tumour Biol; 2012 Aug; 33(4):1125-32. PubMed ID: 22359202
[TBL] [Abstract][Full Text] [Related]
2. Does cytochrome P450 1A1 MspI polymorphism increase acute lymphoblastic leukemia risk? Evidence from 2013 cases and 2903 controls.
Zhuo W; Zhang L; Qiu Z; Zhu B; Chen Z
Gene; 2012 Nov; 510(1):14-21. PubMed ID: 22964275
[TBL] [Abstract][Full Text] [Related]
3. CYP1A1 MspI polymorphism is associated with prostate cancer susceptibility: evidence from a meta-analysis.
Ding G; Xu W; Liu H; Zhang M; Huang Q; Liao Z
Mol Biol Rep; 2013 May; 40(5):3483-91. PubMed ID: 23475304
[TBL] [Abstract][Full Text] [Related]
4. The effect of CYP1A1 and CYP1A2 polymorphisms on gastric cancer risk among different ethnicities: a systematic review and meta-analysis.
Xue H; Lu Y; Xue Z; Lin B; Chen J; Tang F; Huang G
Tumour Biol; 2014 May; 35(5):4741-56. PubMed ID: 24443269
[TBL] [Abstract][Full Text] [Related]
5. The cytochrome P4501A1 gene polymorphisms and endometriosis: a meta-analysis.
Fan W; Huang Z; Xiao Z; Li S; Ma Q
J Assist Reprod Genet; 2016 Oct; 33(10):1373-1383. PubMed ID: 27525656
[TBL] [Abstract][Full Text] [Related]
6. CYP1A1 MspI and exon7 gene polymorphisms and lung cancer risk: an updated meta-analysis and review.
Zhan P; Wang Q; Qian Q; Wei SZ; Yu LK
J Exp Clin Cancer Res; 2011 Oct; 30(1):99. PubMed ID: 22014025
[TBL] [Abstract][Full Text] [Related]
7. Association between cytochrome P450 1A1 MspI polymorphism and endometrial cancer risk: a meta-analysis.
Han L; Liu Y; Cao W; Yuan X; Li C
Tumour Biol; 2013 Oct; 34(5):2545-50. PubMed ID: 23918309
[TBL] [Abstract][Full Text] [Related]
8. Meta-analysis of association studies of CYP1A1 genetic polymorphisms with digestive tract cancer susceptibility in Chinese.
Liu C; Jiang Z; Deng QX; Zhao YN
Asian Pac J Cancer Prev; 2014; 15(11):4689-95. PubMed ID: 24969905
[TBL] [Abstract][Full Text] [Related]
9. MspI and Ile462Val polymorphisms in CYP1A1 and overall cancer risk: a meta-analysis.
Wu B; Liu K; Huang H; Yuan J; Yuan W; Wang S; Chen T; Zhao H; Yin C
PLoS One; 2013; 8(12):e85166. PubMed ID: 24391993
[TBL] [Abstract][Full Text] [Related]
10. Combined effects of CYP1A1 MspI and GSTM1 genetic polymorphisms on risk of lung cancer: an updated meta-analysis.
Li W; Song LQ; Tan J
Tumour Biol; 2014 Sep; 35(9):9281-90. PubMed ID: 24938875
[TBL] [Abstract][Full Text] [Related]
11. Association of CYP1A1 MspI polymorphism in the esophageal cancer risk: a meta-analysis in the Chinese population.
Zheng H; Zhao Y
Eur J Med Res; 2015 Mar; 20(1):46. PubMed ID: 25886559
[TBL] [Abstract][Full Text] [Related]
12. CYP1A1 Ile462Val is a risk factor for ovarian cancer development.
Huang M; Chen Q; Xiao J; Zhao X; Liu C
Cytokine; 2012 Apr; 58(1):73-8. PubMed ID: 22277800
[TBL] [Abstract][Full Text] [Related]
13. Cytochrome P450 1A1 (CYP1A1) gene polymorphisms and ovarian cancer risk: a meta-analysis.
Sergentanis TN; Economopoulos KP; Choussein S; Vlahos NF
Mol Biol Rep; 2012 Nov; 39(11):9921-30. PubMed ID: 22733497
[TBL] [Abstract][Full Text] [Related]
14. Meta-analysis of the association of CYP1A1 polymorphisms with gastric cancer susceptibility and interaction with tobacco smoking.
Han F; Wang X; Wang X; Luo Y; Li W
Mol Biol Rep; 2012 Aug; 39(8):8335-44. PubMed ID: 22707145
[TBL] [Abstract][Full Text] [Related]
15. Significant association between CYP1A1 T3801C polymorphism and cervical neoplasia risk: a systematic review and meta-analysis.
Xia L; Gao J; Liu Y; Wu K
Tumour Biol; 2013 Feb; 34(1):223-30. PubMed ID: 23055196
[TBL] [Abstract][Full Text] [Related]
16. Functional CYP1A1 genetic variants, alone and in combination with smoking, contribute to development of head and neck cancers.
Liu L; Wu G; Xue F; Li Y; Shi J; Han J; Zhang X; Na Y; Zhang H; Tang X; Pu H; Yuan Q; Zhang L; Yang M
Eur J Cancer; 2013 Jun; 49(9):2143-51. PubMed ID: 23462525
[TBL] [Abstract][Full Text] [Related]
17. Association between CYP1A1 Ile462Val variation and acute leukemia risk: meta-analyses including 2164 cases and 4160 controls.
Zhuo W; Zhang L; Zhu B; Qiu Z; Chen Z
PLoS One; 2012; 7(10):e46974. PubMed ID: 23056546
[TBL] [Abstract][Full Text] [Related]
18. Interactions between CYP1A1 polymorphisms and cigarette smoking are associated with the risk of hepatocellular carcinoma: evidence from epidemiological studies.
Yu L; Sun L; Jiang YF; Lu BL; Sun DR; Zhu LY
Mol Biol Rep; 2012 Jun; 39(6):6641-6. PubMed ID: 22297691
[TBL] [Abstract][Full Text] [Related]
19. Lack of association between CYP1A1 polymorphisms and risk of bladder cancer: a meta-analysis.
Lu Y; Zhang XL; Xie L; Li TJ; He Y; Peng QL; Deng Y; Wang J; Qin X; Li S
Asian Pac J Cancer Prev; 2014; 15(9):4071-7. PubMed ID: 24935599
[TBL] [Abstract][Full Text] [Related]
20. CYP1A1 MspI polymorphism and acute myeloid leukemia risk: meta-analyses based on 5018 subjects.
Zhuo W; Zhang L; Wang Y; Zhu B; Chen Z
J Exp Clin Cancer Res; 2012 Jul; 31(1):62. PubMed ID: 22846179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
